ISTH news and updates: Join the ISTH today – student membership is now free!
ISTH Academy, Faculty / Presenter(s), 290459
In vitro flow based systems to study platelet function and thrombus formation: Recommendations for standardization: Communication from the SSC on Biorheology of the ISTH
ISTH Academy, Mikhail Panteleev, 290460
What the neighbors say
ISTH Academy, Faculty / Presenter(s), 290461
Laboratory monitoring during pregnancy and post‐partum hemorrhage in women with von Willebrand disease
ISTH Academy, Sarah H. O‘Brien, 290462
Response to: Direct oral anticoagulants: Still too early for prime time after pulmonary endarterectomy?
ISTH Academy, Pierre TRINH-DUC, 290463
Antithrombin: An anticoagulant, anti‐inflammatory and antibacterial serpin
ISTH Academy, Sarah H. O‘Brien, 290464
Hemostatic effect of tranexamic acid combined with factor VIII concentrate in prophylactic setting in severe hemophilia A: A preclinical study
ISTH Academy, Yesim Dargaud, 290465
Comparative validation study of risk assessment models for pediatric hospital‐acquired venous thromboembolism
ISTH Academy, Arash Mahajerin, 290466
Validation of the ISTH/SSC bleeding assessment tool for inherited platelet disorders: A communication from the Platelet Physiology SSC
ISTH Academy, Paolo Gresele, 290467
Commentary on: Comparison of three transfusion protocols prior to central venous catheterization in patients with cirrhosis: A randomized controlled trial
ISTH Academy, Nicolas Intagliata, 290468
Direct oral anticoagulants: Still too early for prime time after pulmonary endarteriectomy?
ISTH Academy, Laurent Bertoletti, 290469
Acquired Glanzmann thrombasthenia associated with platelet desialylation
ISTH Academy, Shiying Silvia Zheng, 290470
Clinical pre‐test probability adjusted versus age‐adjusted D‐dimer interpretation strategy for DVT diagnosis: A diagnostic individual patient data meta‐analysis
ISTH Academy, Sameer Parpia, 290471
Reply to “Comment on ‘Comparison of three transfusion protocols prior to central venous catheterization in patients with cirrhosis; a randomized controlled trial’”
ISTH Academy, Leonardo L. Rocha, 290474
Ticagrelor attenuates the increase of extracellular vesicle concentrations in plasma after acute myocardial infarction compared to clopidogrel
ISTH Academy, Aleksandra Gasecka, 290475
Patients with aortic stenosis have von Willebrand factor abnormalities and increased proliferation of endothelial colony forming cells
ISTH Academy, Paula James, 290476
Comment on Comparison of three transfusion protocols prior to central venous catheterisation in patients with cirrhosis; a randomised controlled trial
ISTH Academy, Brian J HOGAN, 290477
Response to letter to the Editor: Direct oral anticoagulants in thrombotic antiphospholipid syndrome associated with chronic thromboembolic pulmonary hypertension
ISTH Academy, Pierre TRINH-DUC, 290478
Von Willebrand factor and ADAMTS13 impact on the outcome of Staphylococcus aureus sepsis
ISTH Academy, Peter Verhamme, 290479
May‐Thurner syndrome: History of understanding and need for defining population prevalence
ISTH Academy, Michelle M. Harbin, 290480
Molecular mechanism of two nanobodies that inhibit PAI‐1 activity reveals a modulation at distinct stages of the PAI‐1/plasminogen activator interaction
ISTH Academy, Paul Declerck, 290481
Platelet lipidome: Dismantling the “Trojan horse” in the bloodstream
ISTH Academy, Madhumita Chatterjee, 290482
Clinical outcomes of isolated distal deep vein thrombosis versus proximal venous thromboembolism in cancer patients: The Cleveland Clinic experience
ISTH Academy, Dana Angelini, 290483
Increased platelet procoagulant potential predicts recurrent stroke and TIA after lacunar infarction
ISTH Academy, Calin I. Prodan, 290484
The intestinal microbiome potentially affects thrombin generation in human subjects
ISTH Academy, Thijs Van Mens, 290485
Issue Information
ISTH Academy, Faculty / Presenter(s), 290486
Defining trauma‐induced coagulopathy with respect to future implications for patient management: Communication from the SSC of the ISTH
ISTH Academy, Paul Kim, 290487
Validation of the VTE‐BLEED score’s long‐term performance for major bleeding in patients with venous thromboembolisms: From the COMMAND VTE registry
ISTH Academy, Yugo Yamashita, 290490
Hemostasis and anticoagulation in patients with liver dysfunction
ISTH Academy, Armando Tripodi & Nicolas Intagliata, 288304
Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia
ISTH Academy, Ziyong Sun, 290504
Opening Doors to Open Access Publishing
ISTH Academy, Mary Cushman and Kaia Motter, 288193
Opening Doors to Open Access Publishing
ISTH Academy, Mary Cushman and Kaia Motter, 289244
Physiopathology and treatment of acquired coagulopathies
ISTH Academy, Karim Brohi & Beverly Hunt, 287999
Unaccompanied mechanosensory domain mediates low expression of glycoprotein Ibα: implications for Bernard‐Soulier syndrome
ISTH Academy, Renhao Li, 288004
The prevention and management of asparaginase‐related venous thromboembolism in adults: Guidance from the SSC on Hemostasis and Malignancy of the ISTH
ISTH Academy, Jeffrey Zwicker, 288005
Hemostasis and thrombosis 101—A challenge to energize
ISTH Academy, Faculty / Presenter(s), 288006
Reply to Thromboprophylaxis in temporary lower limb immobilization: Extrapolate with care
ISTH Academy, Daniel Horner, 288007
ISTH news and updates: Join the ISTH today – student membership is now free!
ISTH Academy, Faculty / Presenter(s), 288008
Apixaban and dalteparin in active malignancy‐associated venous thromboembolism: The ADAM VTE trial
ISTH Academy, Robert McBane, 288009
Antigen‐specific in vitro expansion of factor VIII‐specific regulatory T cells induces tolerance in hemophilia A mice
ISTH Academy, Carol H. Miao, 288010
A mathematical model of coagulation under flow identifies factor V as a modifier of thrombin generation in hemophilia A
ISTH Academy, Antonio Formentin, 288011
Reply to: Clinical impact of high platelet count and high hematocrit, by Marc Sorigue
ISTH Academy, Borge Nordestgaard, 288012
Efficacy and safety of open‐label caplacizumab in patients with exacerbations of acquired thrombotic thrombocytopenic purpura in the HERCULES study
ISTH Academy, Carol H. Miao, 288013
Characterization of the interaction between platelet factor 4 and homogeneous synthetic low molecular weight heparins
ISTH Academy, Carol H. Miao, 288014
Thrombin activatable fibrinolysis inhibitor pathway alterations correlate with bleeding phenotype in patients with severe hemophilia A
ISTH Academy, Mario Colucci, 288015
Unique surface‐exposed hydrophobic residues in the C1 domain of factor VIII contribute to cofactor function and von Willebrand factor binding
ISTH Academy, Alexander Meijer, 288016
Clinical impact of high platelet count and high hematocrit
ISTH Academy, Marc Sorigue, 288017
What the neighbors say
ISTH Academy, Faculty / Presenter(s), 288018
One piece of the puzzle: Population pharmacokinetics of FVIII during perioperative Haemate P/Humate P treatment in von Willebrand disease patients
ISTH Academy, Marc Sorigue, 288019
Antidepressant drug use and subdural hematoma risk
ISTH Academy, Marc Sorigue, 288020
Efficacy of fibrinogen concentrate in major abdominal surgery – A prospective, randomized, controlled study in cytoreductive surgery for pseudomyxoma peritonei
ISTH Academy, Faheez Mohamed, 288021
Pharmacological thromboprophylaxis to prevent venous thromboembolism in patients with temporary lower limb immobilization after injury: systematic review and network meta‐analysis
ISTH Academy, Daniel Horner, 288022
Ability of a single negative ultrasound to rule out deep vein thrombosis in pregnant women: A systematic review and meta‐analysis
ISTH Academy, Kumait Al Lawati, 288023
Detection of anti‐domain I antibodies by chemiluminescence enables the identification of high‐risk antiphospholipid syndrome patients: A multicenter multiplatform study
ISTH Academy, Katrien Devreese, 288024
Knock‐in mice bearing constitutively active αIIb(R990W) mutation develop macrothrombocytopenia with severe platelet dysfunction
ISTH Academy, Hirokazu Kashiwagi, 288025
Pharmacokinetics, immunogenicity, safety, and preliminary efficacy of subcutaneous turoctocog alfa pegol in previously treated patients with severe hemophilia A (alleviate 1)
ISTH Academy, Clemens Feistritzer, 288026
Validity and reliability of the Colorado Adult Joint Assessment Scale in adults with moderate‐severe hemophilia A
ISTH Academy, Sharon M. Funk, 288027
Thromboprophylaxis in temporary lower limb immobilization: Extrapolate with care
ISTH Academy, Sharon M. Funk, 288028
Inhibition of triggering receptor expressed on myeloid cells‐1 impairs thrombin generation
ISTH Academy, Sébastien Gibot, 288029
Burden of rare exome sequence variants in PROC gene is associated with venous thromboembolism: a population‐based study
ISTH Academy, Weihong Tang, 288030
Recommendations for clinical laboratory testing for protein C deficiency, for the subcommittee on plasma coagulation inhibitors of the ISTH
ISTH Academy, Peter C. Cooper, 288031
Prevention of venous thromboembolism in medical cancer patients: Guidance or guideline?
ISTH Academy, James Douketis, 288032
Interspecies differences in protein expression do not impact the spatiotemporal regulation of glycoprotein VI mediated activation
ISTH Academy, Alice Y. Pollitt, 288033
Issue Information
ISTH Academy, Faculty / Presenter(s), 288034
Lupus anticoagulant assay cut‐offs vary between reagents even when derived from a common set of normal donor plasmas
ISTH Academy, Gary Moore, 288035
Effect of blood flow on platelets, leukocytes, and extracellular vesicles in thrombosis of simulated neonatal extracorporeal circulation
ISTH Academy, Andrew D. Meyer, 288036
ISTH Academy, Faculty / Presenter(s), 287854
Persistence of oral anticoagulant treatment for atrial fibrillation in the Netherlands: A surveillance study
ISTH Academy, Willem Lijfering, 287855
Not all (N)SAID and done: Effects of nonsteroidal anti‐inflammatory drugs and paracetamol intake on platelets
ISTH Academy, Dianne E. van der Wal, 287856
RNA expression and risk of venous thromboembolism in lung cancer
ISTH Academy, Alok Khorana, 287857
The clinical heterogeneity of RUNX1 associated familial platelet disorder with predisposition to myeloid malignancy – A case series and review of the literature
ISTH Academy, Catherine Tang, 287858
Assessing plasminogen activation potential with global fibrinolytic assays
ISTH Academy, Tetsumei Urano, 287859
The effect of unfractionated heparin, enoxaparin, and danaparoid on lupus anticoagulant testing: Can activated carbon eliminate false‐positive results?
ISTH Academy, Katrien Devreese, 287860
A method to determine if more than surrogate outcomes were improved: The EMR glitch experiment
ISTH Academy, Vinay Prasad, 287861
All bleeding matters … but the details may not
ISTH Academy, Sarah OBrien, 287862
Perioperative interruption of direct oral anticoagulants and vitamin K antagonists in patients with atrial fibrillation: A comparative analysis
ISTH Academy, Marc Carrier, 287863
Microfluidic hemophilia models using blood from healthy donors
ISTH Academy, Scott L. Diamond, 287864
Looking forward by looking back: Inception of a new journal
ISTH Academy, Mary Cushman, 287865
The dual role of platelet‐innate immune cell interactions in thrombo‐inflammation
ISTH Academy, Julie Rayes, 287866
Bleeding assessment tools to predict von Willebrand disease: Utility of individual bleeding symptoms
ISTH Academy, Paula James, 287867
Development and application of global assays of hyper‐ and hypofibrinolysis
ISTH Academy, Nigel Key, 287868
Modified application of Kawamoto’s film method for super‐resolution imaging of megakaryocytes in undecalcified bone marrow
ISTH Academy, Yosuke Morodomi, 287869
Factor XIII deficiency does not prevent FeCl‐induced carotid artery thrombus formation in mice
ISTH Academy, Alisa Wolberg, 287870
ISTH Academy, Faculty / Presenter(s), 287872
Clinical variables that increase the probability of pulmonary embolism diagnosis in symptomatic children
ISTH Academy, Jeffrey Kline, 287873
A rat model of severe VWD by elimination of the VWF gene using CRISPR/Cas9
ISTH Academy, Robert Montgomery, 287874
Congenital platelet disorders and health status–related quality of life
ISTH Academy, Roger Schutgens, 287875
3D ultrastructural analysis of α‐granule, dense granule, mitochondria, and canalicular system arrangement in resting human platelets
ISTH Academy, Brian Storrie, 287876
Direct oral anticoagulants in antiphospholipid syndrome with venous thromboembolism: Impact of the European Medicines Agency guidance
ISTH Academy, Scott Woller, 287877
Paul E. Bock, PhD (21 October, 1949–11 October, 2019)
ISTH Academy, Faculty / Presenter(s), 287589
What the neighbors say
ISTH Academy, Faculty / Presenter(s), 287590
Phagocytosis by endothelial cells inhibits procoagulant activity of platelets of essential thrombocythemia in vitro
ISTH Academy, Chunyan Gao, 287591
A multicenter study of anticoagulation in operable chronic thromboembolic pulmonary hypertension
ISTH Academy, Mark Toshner, 287592
Screening pulmonary angiogram and the effect on anticoagulation strategies in severe respiratory failure patients on venovenous extracorporeal membrane oxygenation
ISTH Academy, Emma L. Hartley, 287593
Cell type‐specific mechanisms coupling protease‐activated receptor‐1 to infectious colitis pathogenesis
ISTH Academy, Joseph Palumbo, 287605
ISTH News and Updates: Join the ISTH Today – Student Membership is Now Free!
ISTH Academy, Faculty / Presenter(s), 287606
ISTH Academy, Faculty / Presenter(s), 287607
Novel inhibitor ZED3197 as potential drug candidate in anticoagulation targeting coagulation FXIIIa (F13a)
ISTH Academy, Ralf Pasternack, 287608
Professor Russell F. Doolittle (1931‐2019)
ISTH Academy, Faculty / Presenter(s), 287609

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.

Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.

Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.

Save Settings